Cartography Biosciences · 1 day ago
Associate Director / Director, Business Development
Cartography Biosciences is a therapeutics organization focused on creating innovative cancer therapies. The Associate Director / Director will play a key role in business development, collaborating with various teams to execute corporate strategy and support capital strategy efforts.
BiopharmaBiotechnologyLife ScienceOncology
Responsibilities
Work closely with the Head of Business Development and cross-functional stakeholders (e.g., R&D, Finance, Legal, etc.) to support key strategic goals and execute strategic alliances and transactions
Lead the research and analysis of partnering opportunities, including comps, business case development, and valuation models
Drive commercial assessments, revenue forecasts and planning for internal programs and external asset opportunities for priority diseases as identified in collaboration with clinical, scientific and business leadership
Support capital and financing-related activities by preparing analyses and materials used in investor, banker, and strategic partner discussions, including transaction scenarios, asset positioning, and value drivers relevant to private and public capital markets
Manage partnering process including deal structuring / term sheet development, financial analysis of economic terms, coordinating diligence, supporting negotiation and execution of definitive agreements
Coordinate alliance management activities with new and existing partners to ensure contractual obligations, governance processes, and strategic objectives are met, while supporting consistent internal and external messaging
Partner with cross-functional stakeholders to ensure consistent, accurate, and compelling external communication of corporate strategy, pipeline progress, and partnering activities across investor presentations, press releases, and other external-facing materials
Monitor industry trends, competitive landscape, and emerging technologies in the biopharma space, including tracking relevant IPOs, financings, and partnership structures to inform corporate and business development strategy
Assist in the development of presentations and materials for senior management and the Board of Directors, including content supporting strategic planning, partnering decisions, and capital or IPO readiness initiatives
Attend partnering conferences, scientific congresses, and networking events on behalf of company to build relationships with prospective partners, investors, and other external stakeholders
Qualification
Required
6+ years of experience in the biopharma or related industry (i.e. investment banking, management consulting, venture capital), with exposure to transactions and capital-related initiatives
BA, BS or equivalent required
Demonstrated ability to work cross functionally on multiple projects simultaneously with the ability to influence and drive stakeholders to decisions
Strong quantitative and qualitative analytical skills, including financial modeling and valuation, with the ability to analyze complex business opportunities and the financial and strategic implications
Experience supporting market assessments, portfolio prioritization, or long-range planning efforts, and translating clinical, commercial, and financial analyses into clear recommendations for leadership
High attention to detail, sound judgment, and a disciplined, fact-based approach to decision-making in high-visibility and time-sensitive environments
Exceptional written and oral communication skills with the ability to build relationships and interact effectively with stakeholders at various levels
Preferred
MBA degree or other advanced degree in a related field (MD, PharmD, MS or PhD) preferred
Prior experience in biopharma partnering, including search and evaluation, transaction execution, or alliance support; familiarity with how partnerships intersect with financing and company-building stages is a plus
Company
Cartography Biosciences
Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.
Funding
Current Stage
Growth StageTotal Funding
$124MKey Investors
Pfizer Venture Investments8VC
2025-10-02Series B· $67M
2022-07-19Series A· $57M
Leadership Team
Recent News
Andreessen Horowitz
2026-01-19
2026-01-07
2026-01-07
Company data provided by crunchbase